中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

原发性胆汁性胆管炎乏力机制与治疗进展

赵健 曹嘉 姚定康

引用本文:
Citation:

原发性胆汁性胆管炎乏力机制与治疗进展

DOI: 10.3969/j.issn.1001-5256.2016.11.050
详细信息
  • 中图分类号: R575.7

Research advances in pathogenesis and management of fatigue in patients with primary biliary cirrhosis

  • 摘要: 乏力是原发性胆汁性胆管炎(PBC)最常见的症状之一,严重影响患者的生活质量。其发病机制尚不清楚,也尚无明确有效的治疗方法。回顾了PBC乏力的发病机制与治疗的最新进展,研究表明PBC乏力病因包括大脑改变、睡眠障碍、抑郁、自主神经功能失调、肌肉代谢异常等多种中枢性与周围性因素;而莫达非尼治疗PBC乏力的疗效尚不确切。在PBC乏力的病因与治疗领域还需要深入的系统性研究。

     

  • [1]AL-HARTHY N,KUMAGI T,COLTESCU C,et al.The specificity of fatigue in primary biliary cirrhosis:evaluation of a large clinic practice[J].Hepatology,2010,52(2):562-570.
    [2]GU EL,YAO GB.The clinical characteristics of primary biliary cirrhosis in China:a systimatic review[J].Chin J Hepatol,2009,17(11):861-866.(in Chinese)顾而立,姚光弼.中国人原发性胆汁性肝硬化的临床特点:52年文献的系统分析[J].中华肝脏病杂志,2009,17(11):861-866.
    [3]CAUCH-DUDEK K,ABBEY S,STEWART DE,et al.Fatigue in primary biliary cirrhosis[J].Gut,1998,43(5):705-710.
    [4]HUET PM,DESLAURIERS J,TRAN A,et al.Impact of fatigue on the quality of life of patients with primary biliary cirrhosis[J].Am J Gastroenterol,2000,95(3):760-767.
    [5]MELLS GF,PELLS G,NEWTON JL,et al.Impact of primary biliary cirrhosis on perceived quality of life:the UK-PBC national study[J].Hepatology,2013,58(1):273-283.
    [6]QUARNETI C,MURATORI P,LALANNE C,et al.Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis[J].Liver Int,2015,35(2):636-641.
    [7]JONES DE,AL-RIFAI A,FRITH J,et al.The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis:results of a 9 year follow-up[J].J Hepatol,2010,53(5):911-917.
    [8]BJORNSSON E,KALAITZAKIS E,NEUHAUSER M,et al.Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up[J].Liver Int,2010,30(2):251-258.
    [9]FORTON DM,PATEL N,PRINCE M,et al.Fatigue and primary biliary cirrhosis:association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels[J].Gut,2004,53(4):587-592.
    [10]HOLLINGSWORTH K,JONES DE,EL-SHARKAWY A,et al.Autonomic dysfunction in primary biliary cirrhosis is associated with structural brain abnormalities,particularly in the globus pal idus[J].Hepatology,2007,46(Suppl 4):546a-547a.
    [11]McD ONALD C,NEWTON J,LAI HM,et al.Central nervous system dysfunction in primary biliary cirrhosis and its relationship to symptoms[J].J Hepatol,2010,53(6):1095-1100.
    [12]Mc DONALD C,BAKER S,LAI M,et al.Central cerebral activation is reduced in primary biliary cirrhosis and associated with excessive daytime sleepiness[J].Hepatology,2007,46(Suppl 4):546a.
    [13]MONTAGNESE S,NSEMI LM,CAZZAGON N,et al.SleepWake profiles in patients with primary biliary cirrhosis[J].Liver Int,2013,33(2):203-209.
    [14]NEWTON JL,GIBSON GJ,TOMLINSON M,et al.Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence[J].Hepatology,2006,44(1):91-98.
    [15]BLACKBURN P,FREESTON M,BAKER CR,et al.The role of psychological factors in the fatigue of primary biliary cirrhosis[J].Liver Int,2007,27(5):654-661.
    [16]JONES DE.Fatigue in cholestatic liver disease:is it all in the mind?[J].J Hepatol,2007,46(6):992-994.
    [17]van OS E,van DEN BROEK WW,MULDER PG,et al.Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis[J].J Hepatol,2007,46(6):1099-1103.
    [18]TALWALKAR JA,DONLINGER JJ,GOSSARD AA,et al.Fluoxetine for the treatment of fatigue in primary biliary cirrhosis:a randomized,double-blind control ed trial[J].Dig Dis Sci,2006,51(11):1985-1991.
    [19]FRITH J,NEWTON JL.Autonomic dysfunction in chronic liver disease[J].Hepat Med,2011,3:81-87.
    [20]PRICE JK,ESCHEIK C,WEINSTEIN AA,et al.Medications affecting the autonomic nervous system(ANS)do not explain abnormal diastolic blood pressure in patients with chronic hepatitis C(Ch-C)or non-alcoholic fatty liver disease(NAFLD)[J].Gastroenterology,2013,1441(5):s969.
    [21]DYSON JK,ELSHARKAWY AM,LAMB CA,et al.Fatigue in primary sclerosing cholangitis is associated with sympathetic over-activity and increased cardiac output[J].Liver Int,2015,35(5):1633-1641.
    [22]CARBONE M,MELLS GF,PELLS G,et al.Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid[J].Gastroenterology,2013,144(3):560-569,e13-e14.
    [23]NEWTON JL,HUDSON M,TACHTATZIS P,et al.Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis[J].Hepatology,2007,45(6):1496-1505.
    [24]NEWTON JL,DAVIDSON A,KERR S,et al.Autonomic dysfunction in primary biliary cirrhosis correlates with fatigue severity[J].Eur J Gastroenterol Hepatol,2007,19(2):125-132.
    [25]HOLLINGSWORTH KG,NEWTON JL,TAYLOR R,et al.Pilot study of peripheral muscle function in primary biliary cirrhosis:potential implications for fatigue pathogenesis[J].Clin Gastroenterol Hepatol,2008,6(9):1041-1048.
    [26]HOLLINGSWORTH KG,MACGOWAN GA,MORRIS L,et al.Cardiac torsion-strain relationships in fatigued primary biliary cirrhosis patients show accelerated aging:a pilot cross-sectional study[J].J Appl Physiol(1985),2012,112(12):2043-2048.
    [27]EKERFORS U,SUNNERHAGEN KS,WESTIN J,et al.Muscle performance and fatigue in non-advanced chronic liver disease[J].Gastroenterology,2015,1481(4):s991.
    [28]RUDIC JS,POROPAT G,KRSTIC MN,et al.Ursodeoxycholic acid for primary biliary cirrhosis[J].Cochrane Database Syst Rev,2012,12:CD000551.
    [29]WANG X,WANG JB.The diagnosis and treatment of primary biliary citthosis[J].J Clin Hepatol,2015,31(10):1605-1607.(in Chinese)王眭,王江滨.原发性胆汁性肝硬化的诊断与治疗[J].临床肝胆病杂志,2015,31(10):1605-1607.
    [30]KAPLAN MM,BONIS PA.Modafinil for the treatment of fatigue in primary biliary cirrhosis[J].Ann Intern Med,2005,143(7):546-547.
    [31]JONES DE,NEWTON JL.An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis[J].Aliment Pharmacol Ther,2007,25(4):471-476.
    [32]IAN GS,de JONGH M,KAPLAN MM.Modafinil in the treatment of debilitating fatigue in primary biliary cirrhosis:a clinical experience[J].Dig Dis Sci,2009,54(10):2242-2246.
    [33]SILVEIRA MG,GOSSARD AA,STAHLER AC,et al.A randomized,placebo-controlled clinical trial of efficacy and safety:modafinil in the treatment of fatigue in patients with primary biliary cirrhosis[J].Am J Ther,2016.[Epub ahead of print]
    [34]TAN YG,YAN HP,GAO ZH.Research progress in role of B cell immunity in primary biliary cirrhosis[J].J Clin Hepatol,2014,30(5):400-404.(in Chinese)谭延国,闫惠平,高祖华.原发性胆汁性肝硬化中B细胞免疫的研究进展[J].临床肝胆病杂志,2014,30(5):400-404.
    [35]MYERS RP,SWAIN MG,LEE SS,et al.B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid[J].Am J Gastroenterol,2013,108(6):933-941.
    [36]JOPSON L,NEWTON JL,PALMER J,et al.RITPBC:Bcell depleting therapy(rituximab)as a treatment for fatigue in primary biliary cirrhosis:study protocol for a randomised controlled trial[J].BMJ Open,2015,5(8):e7985.
    [37]CARBONE M,BUFTON S,MONACO A,et al.The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis:a prospective study[J].J Hepatol,2013,59(3):490-494.
    [38]PELLS G,MELLS GF,CARBONE M,et al.The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort[J].J Hepatol,2013,59(1):67-73.
  • 加载中
计量
  • 文章访问数:  2523
  • HTML全文浏览量:  8
  • PDF下载量:  506
  • 被引次数: 0
出版历程
  • 收稿日期:  2016-06-08
  • 出版日期:  2016-11-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回